The beta-glucan market was valued at USD 307.8 million in 2016, and is expected to grow at a CAGR of 7.57%, to reach USD 476.5 million by 2022. The market is primarily driven by factors such as growing health consciousness among consumers and the increasing health expenditure. North America is projected to be the fastest-growing region as the consumers in are gradually becoming aware of the health benefits of oat beta-glucan and its significance in enhancing the body’s immunity. One of the major restraints in the growth of the beta-glucan market is the inconsistency in regulatory norms governing beta-glucan.
Pharmaceuticals segment is projected to be the fastest-growing application
The pharmaceuticals application of beta-glucan dominates the market due to its ability to cure problems such as obesity, blood pressure, and diabetes. With the increase in the quality and the arrival of clinically proven products in the market, the trust of consumers is growing for these products. The growing market for functional food & beverages is presenting opportunities for the application of beta-glucan in the food & beverage industry.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5191796
North America: High growth is expected in the beta-glucan market
North America is projected to be the fastest-growing market for the period considered for this study as the beta-glucan market here is led by its broad applications in various products, along with their health benefits. The North American region is majorly driven by the U.S. market and the increasing incidences of diseases and widespread application of fibers & specialty ingredients in various food products, beverages, and dietary supplements.
Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=5191796
Key Market Players
Beta-glucan market includes the profiles of leading companies such as Cargill (U.S.), Kerry Group plc (Israel), Tate & Lyle (U.K.), Royal DSM (Netherlands), Ohly (Germany), Frutarom (Israel), MilliporeSigma (U.S.), Super Beta Glucan (U.S.), and Lesaffre Human Care (France).
